FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3190147387> ?p ?o ?g. }

• W3190147387 endingPage "673" @default.
• W3190147387 startingPage "661" @default.
• W3190147387 abstract "Many men receive 5-alpha reductase inhibitors (5ARIs) for ongoing treatment of benign prostatic hyperplasia (BPH). The increased risk of cardiovascular complications with 5ARIs has been documented in BPH studies and the occurrence of cerebral venous thrombosis, presumably due to increased estrogen level following 5ARI use, was described in multiple case reports. The objective of this study was to determine if 5ARIs with or without alpha blockers (AB) were associated with an increased risk of venous thromboembolism (VTE) in males with BPH.We conducted a nested case-control study among a population of men ages 40-79 who received at least one 5ARI or AB prescription for treatment of BPH between 1995 and 2015 in the UK-based Clinical Practice Research Datalink GOLD. Cases of incident VTE (pulmonary embolism [PE] or deep venous thrombosis [DVT]) and matched controls were identified from this population. We used descriptive analyses and conditional logistic regression to evaluate the risk of VTE in users of 5ARIs compared to users of ABs.For 5ARI only users, the adjusted odds ratios (aORs), (95% CI) for VTE were 1.51 (0.98-2.32) in current 5ARI users and 1.23 (0.70-2.17) in recent/distant past, compared to AB only users. However, the aOR (95% CI) in men who had 50 or more current 5ARI prescriptions compared to users of ABs only was higher: 2.29 (1.14-4.63). For 5ARI with AB use, the aORs, (95% CI) for VTE were 1.16 (0.64-2.10) in current 5ARI+AB users and 1.93 (0.71-5.25) in recent/distant past, compared to AB only users. The aOR (95% CI) in men who had 50 or more current 5ARI+AB prescriptions compared to users of ABs only was 1.65 (0.64-4.26).Current use of 5ARI, particularly long-term use, is associated with an increased risk of incident idiopathic VTE compared to patients treated with AB use only." @default.
• W3190147387 created "2021-08-16" @default.
• W3190147387 creator A5025121087 @default.
• W3190147387 creator A5045667842 @default.
• W3190147387 creator A5052539701 @default.
• W3190147387 creator A5083867875 @default.
• W3190147387 date "2021-08-01" @default.
• W3190147387 modified "2023-10-15" @default.
• W3190147387 title "The Risk of Venous Thromboembolism (VTE) in Men with Benign Prostatic Hyperplasia Treated with 5-Alpha Reductase Inhibitors (5ARIs)." @default.
• W3190147387 cites W1467006910 @default.
• W3190147387 cites W1540917239 @default.
• W3190147387 cites W1558621919 @default.
• W3190147387 cites W1569455139 @default.
• W3190147387 cites W1611307986 @default.
• W3190147387 cites W1691887444 @default.
• W3190147387 cites W1707746270 @default.
• W3190147387 cites W1818039308 @default.
• W3190147387 cites W1830737736 @default.
• W3190147387 cites W1964632278 @default.
• W3190147387 cites W1971487571 @default.
• W3190147387 cites W1973572075 @default.
• W3190147387 cites W1974302178 @default.
• W3190147387 cites W1978966708 @default.
• W3190147387 cites W1982313306 @default.
• W3190147387 cites W1991001215 @default.
• W3190147387 cites W2000445173 @default.
• W3190147387 cites W2004150536 @default.
• W3190147387 cites W2010864473 @default.
• W3190147387 cites W2019079287 @default.
• W3190147387 cites W2021678294 @default.
• W3190147387 cites W2028936274 @default.
• W3190147387 cites W2033562626 @default.
• W3190147387 cites W2037699368 @default.
• W3190147387 cites W2042565581 @default.
• W3190147387 cites W2044166399 @default.
• W3190147387 cites W2051592657 @default.
• W3190147387 cites W2055046094 @default.
• W3190147387 cites W2062431789 @default.
• W3190147387 cites W2067890225 @default.
• W3190147387 cites W2074512918 @default.
• W3190147387 cites W2075301817 @default.
• W3190147387 cites W2087107662 @default.
• W3190147387 cites W2088085906 @default.
• W3190147387 cites W2088217716 @default.
• W3190147387 cites W2091362934 @default.
• W3190147387 cites W2107337149 @default.
• W3190147387 cites W2110941928 @default.
• W3190147387 cites W2113820444 @default.
• W3190147387 cites W2122952982 @default.
• W3190147387 cites W2128113477 @default.
• W3190147387 cites W2128543455 @default.
• W3190147387 cites W2140905531 @default.
• W3190147387 cites W2149914864 @default.
• W3190147387 cites W2154692607 @default.
• W3190147387 cites W2395004372 @default.
• W3190147387 cites W2415715163 @default.
• W3190147387 cites W2610994046 @default.
• W3190147387 cites W2910757759 @default.
• W3190147387 cites W2945305468 @default.
• W3190147387 cites W2988664061 @default.
• W3190147387 cites W3028659022 @default.
• W3190147387 cites W3135529189 @default.
• W3190147387 cites W4230100212 @default.
• W3190147387 cites W4297792086 @default.
• W3190147387 cites W4362207783 @default.
• W3190147387 doi "https://doi.org/10.2147/clep.s317019" @default.
• W3190147387 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8349190" @default.
• W3190147387 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34377032" @default.
• W3190147387 hasPublicationYear "2021" @default.
• W3190147387 type Work @default.
• W3190147387 sameAs 3190147387 @default.
• W3190147387 citedByCount "1" @default.
• W3190147387 countsByYear W31901473872022 @default.
• W3190147387 crossrefType "journal-article" @default.
• W3190147387 hasAuthorship W3190147387A5025121087 @default.
• W3190147387 hasAuthorship W3190147387A5045667842 @default.
• W3190147387 hasAuthorship W3190147387A5052539701 @default.
• W3190147387 hasAuthorship W3190147387A5083867875 @default.
• W3190147387 hasBestOaLocation W31901473871 @default.
• W3190147387 hasConcept C121608353 @default.
• W3190147387 hasConcept C126322002 @default.
• W3190147387 hasConcept C141071460 @default.
• W3190147387 hasConcept C151956035 @default.
• W3190147387 hasConcept C156957248 @default.
• W3190147387 hasConcept C2775874879 @default.
• W3190147387 hasConcept C2776235491 @default.
• W3190147387 hasConcept C2776265017 @default.
• W3190147387 hasConcept C2777562237 @default.
• W3190147387 hasConcept C2780011451 @default.
• W3190147387 hasConcept C2780868729 @default.
• W3190147387 hasConcept C2908647359 @default.
• W3190147387 hasConcept C2910366748 @default.
• W3190147387 hasConcept C71924100 @default.
• W3190147387 hasConcept C99454951 @default.
• W3190147387 hasConceptScore W3190147387C121608353 @default.
• W3190147387 hasConceptScore W3190147387C126322002 @default.
• W3190147387 hasConceptScore W3190147387C141071460 @default.
• W3190147387 hasConceptScore W3190147387C151956035 @default.

• next